204 related articles for article (PubMed ID: 16309808)
1. Does domperidone potentiate mirtazapine-associated restless legs syndrome?
Chang CC; Shiah IS; Chang HA; Mao WC
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):316-8. PubMed ID: 16309808
[TBL] [Abstract][Full Text] [Related]
2. Factors potentiating the risk of mirtazapine-associated restless legs syndrome.
Kim SW; Shin IS; Kim JM; Park KH; Youn T; Yoon JS
Hum Psychopharmacol; 2008 Oct; 23(7):615-20. PubMed ID: 18756499
[TBL] [Abstract][Full Text] [Related]
3. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
[No Abstract] [Full Text] [Related]
4. Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS.
Chopra A; Pendergrass DS; Bostwick JM
Psychosomatics; 2011; 52(1):92-4. PubMed ID: 21300203
[No Abstract] [Full Text] [Related]
5. [Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report].
Teive HA; de Quadros A; Barros FC; Werneck LC
Arq Neuropsiquiatr; 2002 Dec; 60(4):1025-9. PubMed ID: 12563401
[TBL] [Abstract][Full Text] [Related]
6. New onset somnambulism associated with different dosage of mirtazapine: a case report.
Yeh YW; Chen CH; Feng HM; Wang SC; Kuo SC; Chen CK
Clin Neuropharmacol; 2009; 32(4):232-3. PubMed ID: 19644232
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine and restless leg syndrome: a case report.
Bonin B; Vandel P; Kantelip JP
Therapie; 2000; 55(5):655-6. PubMed ID: 11201984
[No Abstract] [Full Text] [Related]
8. Akathisia induced by mirtazapine after 20 years of continuous treatment.
Markoula S; Konitsiotis S; Chatzistefanidis D; Lagos G; Kyritsis AP
Clin Neuropharmacol; 2010; 33(1):50-1. PubMed ID: 20124786
[TBL] [Abstract][Full Text] [Related]
9. Restless legs syndrome induced by citalopram: a psychiatric emergency?
Perroud N; Lazignac C; Baleydier B; Cicotti A; Maris S; Damsa C
Gen Hosp Psychiatry; 2007; 29(1):72-4. PubMed ID: 17189751
[TBL] [Abstract][Full Text] [Related]
10. [Restless legs syndrome and depression].
Rasmussen J; Videbech P
Ugeskr Laeger; 2011 Aug; 173(35):2113-7. PubMed ID: 21884661
[TBL] [Abstract][Full Text] [Related]
11. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
[TBL] [Abstract][Full Text] [Related]
13. Acute psychosis associated with dissociated sleep-wakefulness state after mirtazapine treatment.
Felthous AR; Wenger PJ; Hoevet R
Pharmacotherapy; 2010 Apr; 30(4):145e-50e. PubMed ID: 20334466
[TBL] [Abstract][Full Text] [Related]
14. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
[TBL] [Abstract][Full Text] [Related]
15. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
Pharmacopsychiatry; 1997 Nov; 30(6):263-5. PubMed ID: 9442549
[TBL] [Abstract][Full Text] [Related]
16. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
[TBL] [Abstract][Full Text] [Related]
17. Mirtazapine-induced restless legs syndrome treated with pramipexole.
Makiguchi A; Nishida M; Shioda K; Suda S; Nisijima K; Kato S
J Neuropsychiatry Clin Neurosci; 2015; 27(1):e76. PubMed ID: 25716506
[No Abstract] [Full Text] [Related]
18. Mirtazapine may have the propensity for developing a restless legs syndrome? A case report.
Bahk WM; Pae CU; Chae JH; Jun TY; Kim KS
Psychiatry Clin Neurosci; 2002 Apr; 56(2):209-10. PubMed ID: 11952928
[No Abstract] [Full Text] [Related]
19. Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.
Prospero-Garcia KA; Torres-Ruiz A; Ramirez-Bermudez J; Velazquez-Moctezuma J; Arana-Lechuga Y; Teran-Perez G
J Clin Psychiatry; 2006 Nov; 67(11):1820. PubMed ID: 17196069
[No Abstract] [Full Text] [Related]
20. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants.
Leutgeb U; Martus P
Eur J Med Res; 2002 Aug; 7(8):368-78. PubMed ID: 12204845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
